Genky Drugstores reports robust November sales growth
Genky Drugstores Co., Ltd. (TSE:9267) reported substantial growth in its FY2026 November monthly sales bulletin. Net sales for all stores increased by 9.1% year-over-year, reaching 109.1%, while existing stores also saw a healthy 2.2% rise to 102.2%. This growth was primarily driven by a 1.5% increase in customer traffic at existing stores, alongside a 0.7% improvement in spending per customer compared to the previous year.
The company continued its expansion strategy, opening 7 new stores in November, contributing to a total of 493 stores. For the fiscal year ending June 2026, the company recorded a 110.6% increase in net sales for all stores and a 104.3% increase for existing stores, with customer traffic up 3.5% and spending per customer up 0.8%. Genky Drugstores opened 14 new stores and refurbished 4 during the first half of this fiscal year, with one store closing.
These figures reflect the company's monthly closing of accounts and are subject to potential differences from formal financial results. Existing stores are defined as those operating for at least 13 months, with new stores being standardized regular stores, and refurbished stores representing upgrades to the regular store format.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Genky Drugstores publishes news
Free account required • Unsubscribe anytime